Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

HYDROCODONE BITARTRATE

HYDROCODONE BITARTRATE

Standard Dose
60MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary

Approval overview HYDROCODONE BITARTRATE is listed in Drugs@FDA under application 208269 (ANDA).

Marketing status: Prescription Active ingredient HYDROCODONE BITARTRATE Form and strength TABLET, EXTENDED RELEASE;ORAL - 60MG Sponsor ALVOGEN Submission history Latest submission status date: 2024-10-31 00:00:00.

Structured Monograph

Clinical summary

Approval overview HYDROCODONE BITARTRATE is listed in Drugs@FDA under application 208269 (ANDA). Marketing status: Prescription Active ingredient HYDROCODONE BITARTRATE Form and strength TABLET, EXTENDED RELEASE;ORAL - 60MG Sponsor ALVOGEN Submission history Latest submission status date: 2024-10-31 00:00:00. Submission type: SUPPL.

Monitoring

  • • Review priority: N/A
  • • Marketing status: Prescription

Interaction Notes

  • No interaction notes stored yet.
HYDROCODONE BITARTRATE (HYDROCODONE BITARTRATE) | Drug Monograph | MedicHelpline